Justine Cunningham

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Justine Cunningham and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Justine

Justine Cunningham

VP, Toxicology & Biodistribution

Sana Biotechnology, Inc.

Pharmacologist/Toxicologist with experience in development of novel biological therapeutics including gene and stem cell therapies.

Talks About
#biological #toxicology

Preferred Locations
#NorthAmerica

Speaking Engagements

Optimizing AAV Safety Summit

Paid

Welcome to the Optimizing AAV Safety Summit: Predict & Monitor AAV Safety Signals to De-Risk Genetic Therapy Development Hundreds of clinical trials using AAV are underway, with several hundred more in preclinical development.

06-08 September 2022

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Justine Cunningham

VP, Toxicology & Biodistribution

Speaking Engagements

Optimizing AAV Safety Summit